Yi-Bin Chen
Harvard University
H-index: 62
North America-United States
Top articles of Yi-Bin Chen
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Hypoxemic Respiratory Failure Following Ruxolitinib Discontinuation in Allogeneic Hematopoietic Cell Transplantation Recipients | The Oncologist | Annabelle J Anandappa Gabriela S Hobbs Bimalangshu R Dey Areej El-Jawahri Matthew J Frigault | 2021/11/1 |
Outcomes for patients with IDH-mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation | Transplantation and Cellular Therapy | Evan C Chen Shuli Li Ann-Kathrin Eisfeld Marlise R Luskin Alice Mims | 2021/6/1 |
Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma | Blood Advances | Reid W Merryman Robert A Redd Taiga Nishihori Julio Chavez Yago Nieto | 2021/3/23 |
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease | Bone marrow transplantation | Yngvar Fløisand Mark A Schroeder Patrice Chevallier Dominik Selleslag Steven Devine | 2021/10 |
Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease | Bone marrow transplantation | Natasha Kekre Haesook T Kim Julia Hofer Vincent T Ho John Koreth | 2021/5 |
Acute GVHD: do we trust our gut? | Blood, The Journal of the American Society of Hematology | Yi-Bin Chen | 2021/3/18 |
Erythroid nuclear dysplasia is associated with inferior outcomes for patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation | Leukemia Research | Evan C Chen Shuli Li Jiemin Yang M Lisa Zhang Robert Hasserjian | 2021/10/1 |
Evaluation of elafin as a prognostic biomarker in acute graft-versus-host disease | Transplantation and cellular therapy | Makda Getachew Zewde George Morales Isha Gandhi Umut Özbek Paibel Aguayo-Hiraldo | 2021/12/1 |
Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease | Bone marrow transplantation | Natasha Kekre Haesook T Kim Julia Hofer Vincent T Ho John Koreth | 2021/5 |
An N-of-1 Trial of Itacitinib for a Patient with Aplastic Anemia Associated with a Gain-of-Function Variant in STAT1 | Jacob Rosenberg Travis Hughes Joshua Peters Caleb Lareau Leif Ludwig | 2021/1/8 | |
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma | Leukemia | Reid W Merryman Luca Castagna Laura Giordano Vincent T Ho Paolo Corradini | 2021/9 |
Distress in a pandemic: association of the coronavirus disease-2019 pandemic with distress and quality of life in hematopoietic stem cell transplantation | Transplantation and Cellular Therapy | Hermioni L Amonoo Carlisle EW Topping Madison A Clay Matthew J Reynolds Julia Rice | 2021/12/1 |
Acute Myeloid Leukemia Presenting Less Than 3 Weeks After Living Donor Kidney Transplant: A Case Report | Transplantation proceedings | Jielin Yu Bradford Sherburne Yi-Bin Chen Heather L Kutzler Joseph Tremaglio | 2021/5/1 |
Case 26-2021: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia | New England Journal of Medicine | Andrew M Brunner Richard A Newcomb Yi-Bin Chen Andrew M Crabbe | 2021/8/26 |
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: looking forward as the network celebrates its 20th year | Helen E Heslop Edward A Stadtmauer John E Levine Karen K Ballen Yi-Bin Chen | 2021/11/1 | |
Association between baseline patient-reported outcomes and complications of hematopoietic stem cell transplantation | Transplantation and cellular therapy | P Connor Johnson Sunil Bhatt Matthew J Reynolds Tejaswini M Dhawale Nneka Ufere | 2021/6/1 |
Declining bone marrow harvest quality over 24 years: a single institution experience | Bone marrow transplantation | Thomas R Spitzer Se Eun Kim Rachel Cohen Richard Mathews Shuli Li | 2021/4 |
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation | Blood Advances | Matthew J Frigault Philippe Armand Robert A Redd Erin Jeter Reid W Merryman | 2020/1/14 |
Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases | Bone marrow transplantation | Mark Leick Bradley Hunter Zachariah DeFilipp Bimalangshu R Dey Areej El-Jawahri | 2020/4 |
Outcomes of IDH1-and IDH2-Mutated AML Patients Undergoing Allogeneic Hematopoietic Cell Transplantation | Blood | Evan C Chen Shuli Li Ann-Kathrin Eisfeld Marlise R Luskin Alice S Mims | 2020/11/5 |
